BRAIN Biotech AG receives major milestone payment and stays on-track to achieve year end targets
EQS Group
EQS-News: BRAIN Biotech AG / Key word(s): Half Year Results/Half Year Report
BRAIN Biotech AG receives major milestone payment..
EQS-News: BRAIN Biotech AG / Key word(s): Half Year Results/Half Year Report
BRAIN Biotech AG receives major milestone payment..
· Secondary endpoint data for estimated glomerular filtration rate (eGFR) showed numerical improvement over 6 months vs...
– Results from pivotal Phase 2b ReNeu trial of mirdametinib in patients with NF1-PN to be presented in an oral presentation..